Founded

Address

Enobia Pharma Corp
2901 Rachel Street
Suite 23
Montreal QC H1W 4A4
Canada

Open map

Enobia Pharma Corp
2901 Rachel Street Suite 23
Montreal QC H1W 4A4
Canada

Open map

Enobia Pharma Corp
C/o Enobia Pharma Corp 2901 Rachel Street
Suite 23
Montreal QC H1W 4A4
Canada

Open map

Enobia Pharma Corp
C/o Enobia Pharma Inc
2901 Rachel Street Suite 23
Montreal QC H1W 4A4
Canada

Open map

Phone
514-596-2901
Website
http://www.enobia.com

Search trends
Patents
KANDO id: 380701

Corporate information

Official name
Enobia Pharma Corporation
Registration country
Canada

Official identities

US CIK 0001412621

Funding rounds

Acquisition USD 1,100,000,000

USD 1,100,000,000 ( ) at USD 1,100,000,000 pre-money valuation

Profile Country Notes
Alexion Pharmaceuticals Inc Complement inhibition for cardiovascular and inflammatory diseases.
United States
 USD 1,100,000,000 (USD 1,100,000,000)

Series B

( )

Profile Country
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries.
United States

Series C

( )

Profile Country
Desjardins Venture Capital
Canada
T2C2 Capital
Canada

N/A


Profile Country
Solidarity Fund QFL (Fonds de solidarité FTQ), (Fonds de solidarite FTQ)
Canada


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials